US Trends in Prevalence of Sleep Problems and Associations with Chronic Kidney Disease and Mortality.

To better understand the relation between sleep problems and CKD, we examined temporal trends in the prevalence of self-reported sleep problems in adults in the United States and their associations with CKD and all-cause mortality.

Using data from 27,365 adult participants in five biannual National Health and Examination Surveys (2005-2006 through 2013-2014), we studied five self-reported sleep problems-trouble sleeping, sleep disorder, nocturia (urinating ≥2 times/night), inadequate sleep (<7 hours/night), and excessive sleep (>9 hours/night)-plus a composite index. We conducted three types of analysis: temporal trends in the prevalence of each sleep measure by CKD status, using model-based standardization; cross-sectional analysis of associations between four CKD measures and each sleep measure, using logistic regression; and survival analysis of the association between each sleep measure and mortality, using Cox regression.

The prevalence of trouble sleeping and sleep disorder increased over the five surveys by 4% and 3%, respectively, whereas the other sleep problems remained relatively stable. All sleep problems, except inadequate sleep, were more common during the study period among adults with CKD than without CKD (40% versus 21% for nocturia; 5% versus 2% for excessive sleep; 30% versus 25% for trouble sleeping; 12% versus 8% for sleep disorder). Both eGFR <30 ml/min per 1.73 m2 and albuminuria were positively associated with nocturia and excessive sleep. Excessive sleep and nocturia were also associated with higher mortality (adjusted hazard ratio for >9 versus 7-9 hours/night=1.7; 95% CI, 1.3 to 2.1; and for nocturia=1.2; 95% CI, 1.1 to 1.4).

The high prevalence of sleep problems among persons with CKD and their associations with mortality suggest their potential importance to clinical practice. Future work could examine the health effects of identifying and treating sleep problems in patients with CKD.

Kidney360. 2020 May 01*** epublish ***

Monica Shieu, Hal Morgenstern, Jennifer Bragg-Gresham, Brenda W Gillespie, Q Afifa Shamim-Uzzaman, Delphine Tuot, Sharon Saydah, Deborah Rolka, Nilka Rios Burrows, Neil R Powe, Rajiv Saran, Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team

Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan., Kidney Epidemiology and Cost Center, School of Public Health, University of Michigan, Ann Arbor, Michigan., Division of Neurology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan., Departments of Medicine, University of California San Francisco, San Francisco, California., Centers for Disease Control and Prevention, Atlanta, Georgia.